US20130303462A1 - Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome - Google Patents

Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome Download PDF

Info

Publication number
US20130303462A1
US20130303462A1 US13/892,529 US201313892529A US2013303462A1 US 20130303462 A1 US20130303462 A1 US 20130303462A1 US 201313892529 A US201313892529 A US 201313892529A US 2013303462 A1 US2013303462 A1 US 2013303462A1
Authority
US
United States
Prior art keywords
inhibitor
mg
linagliptin
dpp
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/892,529
Inventor
Thomas Klein
Maximilian von EYNATTEN
Berthold Hocher
Michael Mark
Yuliya SHARKOVSKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP12167953.4 priority Critical
Priority to EP12167953 priority
Priority to EP12170888 priority
Priority to EP12170888.7 priority
Priority to EP12006812.7 priority
Priority to EP12006812 priority
Priority to EP12190447 priority
Priority to EP12190447.8 priority
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Assigned to BOEHRINGER INGELHEIM INTERNATIONAL GMBH reassignment BOEHRINGER INGELHEIM INTERNATIONAL GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VON EYNATTEN, Maximilian, SHARKOVSKA, Yuliya, HOCHER, BERTHOLD, KLEIN, THOMAS, MARK, MICHAEL
Publication of US20130303462A1 publication Critical patent/US20130303462A1/en
Application status is Abandoned legal-status Critical

Links